HOME >> MEDICINE >> NEWS
Anti-cocaine vaccine produces antibodies and is shown to be safe in Phase 1 study conducted by Yale researcher

A therapeutic cocaine vaccine designed to suppress the high addicts get from taking cocaine is safe and produced cocaine antibodies in humans, a Yale study finds.

Thomas Kosten, M.D., principal investigator on the phase 1 study, and his team administered the vaccine to 34 former cocaine abusers living in a residential treatment facility.

The vaccine, TA-CD, is designed to generate drug-specific antibodies, which bind to cocaine and prevent it from traveling to the brain from the bloodstream. This neutralizes its psychoactive effect.

"The vaccine is very safe and we did not observe any major side effects," said Kosten, professor of psychiatry at Yale School of Medicine. "TA-CD was effective in producing cocaine-specific antibodies, which lasted throughout the trial. More advanced trials are already underway. TA-CD offers the potential for a completely new and highly viable approach to a very serious problem for which there are no alternative therapies available."

Such a product, Kosten said, would be complementary to behavioral therapy in overcoming cocaine addiction. This vaccine would target the more than two million regular cocaine users in the United States alone. Of these, 900,000 seek treatment each year.

In the Phase 1 trial, the vaccine was given to 34 subjects split into three cohorts to evaluate three different doses of the vaccine following 30 days of abstinence. Two subjects in each cohort received a placebo and the rest received active vaccine. The studys participants had to meet the criteria for cocaine dependence, including a three- to 10-year cocaine habit, and willingness to get treatment and participate in the study.

The people in the study, Kosten said, had a motivation to want to stop using cocaine. This desire to stop is the key factor of any successful treatment outcome.

The vaccine does not take away the desire or the craving for cocaine, Kosten said, but the antibodies it generates block the priming effe
'"/>

Contact: Karen Peart
karen.peart@yale.edu
203-432-1326
Yale University
6-Mar-2000


Page: 1 2

Related medicine news :

1. Pitt marks 50th anniversary of its Salk polio vaccine with reunion, scientific symposium
2. NIAID initiates trial of experimental avian flu vaccine
3. Study finds majority of women willing to accept cervical cancer vaccine for self and children
4. Invasive pneumonia and antibiotic resistance decreased after childhood vaccine introduced
5. Earlier use of prostate cancer vaccines urged by Hopkins scientists
6. Researchers close in on breast cancer vaccine
7. EuroVacc 02 HIV vaccine trial begins in February 2005
8. Varicella vaccine effective on chicken pox; Impact on herpes zoster unclear
9. Pathogen-mimicking vaccine as strategy for cancer therapy
10. HIV vaccine trial breaks ground for future research
11. First US kidney cancer vaccine trial underway at Columbia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2018)... ... , ... The National Cancer Institute estimates that 1.7 million new cases of ... for cancer and we typically associate the disease with old age, about 9 percent ... treatment and advanced therapies, increasing numbers of these patients survive their disease and face ...
(Date:11/15/2018)... ... November 15, 2018 , ... Lisa Vuich MD ... for Specialty MED Training will take the stage during the 26th World ... 2019. Dr. Vuich is leading a CME workshop hosted by Tailor Made Compounding ...
(Date:11/14/2018)... ... November 14, 2018 , ... Entrepreneur ... All-In-One Video Ecommerce Solution, to power its "Ask an Expert" online mentor marketplace. ... live 30 and 60-minute one-to-one virtual sessions that are focused on starting and ...
(Date:11/14/2018)... ... 14, 2018 , ... The Austin-area sports medicine team at Medicine ... pull out the healthcare plan paperwork to review coverage and assess how many unused ... most people can benefit by taking a few minutes for an insurance plan evaluation. ...
(Date:11/13/2018)... ... November 13, 2018 , ... Azzur Labs, ... the opening of its newest laboratory located in Cary, NC. Seated in the ... services to top U.S. manufacturers and brings additional jobs to the Raleigh area. ...
Breaking Medicine News(10 mins):
(Date:11/15/2018)... Del. (PRWEB) , ... November 15, 2018 , ... ... over 61% in 2016 and is estimated to continue its dominance during the ... industrial segment. Mobile exoskeleton provides mobility to the wearer while augmenting strength to ...
(Date:11/15/2018)... Calif. (PRWEB) , ... November 15, 2018 , ... ... instruments, today announced its participation in the California Optometric Association’s Monterey Fall Symposium. ... The show provides a platform for connecting with hundreds of doctors of optometry. ...
(Date:11/14/2018)... ... November 14, 2018 , ... Planet DDS (PDDS), ... Hannah Cohen was joining the company as its new Vice President of Operations. ... DaVita, one of the nation’s leading managed care providers. At DaVita, Hannah oversaw ...
Breaking Medicine Technology:
Cached News: